# Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment

> **NCT01715987** · — · TERMINATED · sponsor: **New Discovery LLC** · enrollment: 48 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Tenofovir Disoproxil Fumarate
- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT01715987
- **Lead sponsor:** New Discovery LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01715987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01715987, "Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01715987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*